Academic Journal

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

التفاصيل البيبلوغرافية
العنوان: Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
المؤلفون: Gian Luca Erre, Marco Sebastiani, Andreina Manfredi, Elisabetta Gerratana, Fabiola Atzeni, Giuseppe Passiu, Arduino A Mangoni
المصدر: Drugs in Context, Vol 10, Pp 1-13 (2021)
بيانات النشر: BioExcel Publishing Ltd, 2021.
سنة النشر: 2021
المجموعة: LCC:Therapeutics. Pharmacology
مصطلحات موضوعية: connective tissue diseases, idiopathic inflammatory myopathies, interstitial lung disease, pirfenidone, nintedanib, rheumatoid arthritis, sjögren’s syndrome, systemic sclerosis, Therapeutics. Pharmacology, RM1-950
الوصف: Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren’s syndrome, idiopathic inflammatory myositis and systemic lupus erythematosus. The treatment of CTD-ILDs is challenging due to the paucity of proven effective treatments. Recently, two antifibrotic drugs conditionally approved for use in patients with idiopathic pulmonary fibrosis, nintedanib and pirfenidone, have been trialled in CTD-ILDs based on overlapping pathological and clinical features between the two diseases. In this narrative review, we discuss the experimental evidence and clinical trials investigating the efficacy and safety of antifibrotic drugs in patients with CTD-ILDs and the potential mechanisms of action involved. Results from clinical trials suggest that nintedanib use retards lung function decline in progressive fibrotic CTD-ILDs. By contrast, the evidence for the efficacy of pirfenidone in these groups is not equally compelling. Further, well-designed randomized clinical trials are needed to evaluate the efficacy and safety of individual antifibrotic drugs in specific CTD-ILD subgroups.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1740-4398
Relation: https://www.drugsincontext.com/antifibrotic-drugs-in-connective-tissue-disease-related-interstitial-lung-disease-(ctd-ild):-from-mechanistic-insights-to-therapeutic-applications; https://doaj.org/toc/1740-4398
DOI: 10.7573/dic.2020-8-6
URL الوصول: https://doaj.org/article/a18ddf36f6374711bdbba8f6d97803fc
رقم الانضمام: edsdoj.18ddf36f6374711bdbba8f6d97803fc
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:17404398
DOI:10.7573/dic.2020-8-6